Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|July 29, 2006
Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugsGeorgio Mosis, Theo Stijnen, Jordi Castellsague, et al.
Pharmacoepidemiology and Drug Safety|December 12, 2012
Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, ItalyJordi Castellsague, Federica Pisa, Valentina Rosolen, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseWayne A Ray, Cristina Varas-Lorenzo, Cecilia P Chung, et al.
Pharmacoepidemiology and Drug Safety|July 26, 2018
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and GermanyJordi Castellsague, Beatriz Poblador-Plou, Maria Giner-Soriano, et al.
Current Drug Safety|October 12, 2013
Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial usersChristine L Bui, James A Kaye, Jordi Castellsague, et al.
Drugs - Real World Outcomes|May 9, 2018
Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort StudyJosephina G Kuiper, Myrthe P P van Herk-Sukel, Jordi Castellsague, et al.
Pharmacoepidemiology and Drug Safety|January 31, 2017
Characterization of new users of cilostazol in the UK, Spain, Sweden, and GermanyJordi Castellsague, Susana Perez-Gutthann, Brian Calingaert, et al.
Pageof 4